AKT1 and cancer: Cells treated with ICGA-A and CRA showed significant enrichment in the “Cancer pathway”, “VEGF pathway”, “PI3K-Akt signaling pathway”, “Focal adhesion pathway”, and “ECM-receptor interaction pathway” (Figures 7B, C).